Two siblings with lipoid congenital adrenal hyperplasia: first reported case in Serbia and literature review.

Background: Lipoid congenital adrenal hyperplasia (LCAH) is an uncommon but life-threatening autosomal recessive disorder. It is caused by a mutation in the steroidogenic acute regulatory protein (StAR), encoded by the Methods: Clinical manifestations of two siblings with primary adrenal insufficiency (PAI) were described. A female infant was admitted to the hospital at six months of age for vomiting and failure to thrive. The diagnosis of PAI of unknown etiology was established. The girl's younger brother was diagnosed with PAI at the age of 1.5 years during a febrile illness. His external genitalia showed undescended testes, scrotal hypoplasia, and hypospadia. Their family history was normal, and both parents were healthy. Clinical exome sequencing was used to identify mutations in candidate genes. Results: Two heterozygous Conclusion: Glucocorticoid, mineralocorticoid, and sex hormone therapy should be individualized according to the clinical presentation and laboratory findings. Because genotype and phenotype do not correlate consistently in LCAH, therapy and follow-up must be individualized.